Stock Events

Stock Events

Iovance Biotherapeutics (0JDK.LSE) Q4 2025 Earnings

6NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.36

-0.32

-0.28

-0.24

Details

Expected EPS

-0.257673

Actual EPS

-0.25

Surprise EPS

0.01

Surprise Percent

+2.98%

Description

Iovance Biotherapeutics (0JDK.LSE) has reported earnings of -0.25 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.